Absorbable and Low-Cost Radioseeds for Malignant Tumors

Information

  • Research Project
  • 7486650
  • ApplicationId
    7486650
  • Core Project Number
    R44CA121641
  • Full Project Number
    4R44CA121641-02
  • Serial Number
    121641
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/11/2006 - 18 years ago
  • Project End Date
    8/31/2009 - 15 years ago
  • Program Officer Name
    WONG, ROSEMARY S.
  • Budget Start Date
    9/13/2007 - 17 years ago
  • Budget End Date
    8/31/2008 - 16 years ago
  • Fiscal Year
    2007
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/13/2007 - 17 years ago
Organizations

Absorbable and Low-Cost Radioseeds for Malignant Tumors

[unreadable] DESCRIPTION (provided by applicant): The objective of this Phase I research is to demonstrate the feasibility of creating timed-bioabsorbable Pd-103 seeds for the treatment of prostate tumors. Timed- bioabsorbable seeds have the combined benefits of titanium seeds, high dose rate temporary seeds, external beam radiation and other treatment options. In addition, timed-bioabsorbable seeds potentially offer desirable post-treatment options, total bioabsorption of the implants and the lowest overall treatment cost. The specific aims of this proposed Fast Track Phase I research are to (1) identify absorbable matrices that have appropriate intrinsic bioabsorption rates and are suitable for engineered control of bioabsorption profiles; (2) determine seed dimension for optimal imaging; (3) control the bioabsorption such that the cumulative Pd-103 radioactivity leakage from seeds is 1% or less and the complete bioabsorption of seed matrices is estimated within 2 years; (4) determine and recommend optimal matrix chemistry and bioabsorption engineering conditions for in-depth studies of Pd-103 leakages and bioabsorption profiles in the Fast-Track Phase II; and (5) demonstrate the biocompatibility for selected timed-bioabsorbable seeds in vitro using ISO methods. Achieving key and measurable milestones set in Phase I will ensure successful completion of the proposed Fast Track Phase II, leading to high impact bioabsorbable seeds for the treatment of prostate tumors and other malignant tumors. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    4
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    361225
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:361225\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    XL SCI-TECH, INC.
  • Organization Department
  • Organization DUNS
    931933824
  • Organization City
    RICHLAND
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    993541663
  • Organization District
    UNITED STATES